These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1460346)

  • 21. Inconsistency of data linking the ryanodine receptor and malignant hyperthermia genes.
    Hopkins PM; Ellis FR; Halsall PJ
    Anesthesiology; 1992 Apr; 76(4):659-61. PubMed ID: 1610471
    [No Abstract]   [Full Text] [Related]  

  • 22. [Molecular pathology of malignant hyperthermia and central core disease].
    Takagi A
    Nihon Rinsho; 1997 Dec; 55(12):3307-14. PubMed ID: 9436456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Diagnosis and therapy of patients with malignant hyperthermia].
    Yumisaku T
    Masui; 2001 Dec; 50 Suppl():S137-43. PubMed ID: 11871088
    [No Abstract]   [Full Text] [Related]  

  • 24. Genomic organization and analysis of the 5' end of the porcine ryanodine receptor gene (ryr1).
    Brenig B; Brem G
    FEBS Lett; 1992 Feb; 298(2-3):277-9. PubMed ID: 1312025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The sarcoplasmic reticulum Ca2+ channel/ryanodine receptor: modulation by endogenous effectors, drugs and disease states.
    Zucchi R; Ronca-Testoni S
    Pharmacol Rev; 1997 Mar; 49(1):1-51. PubMed ID: 9085308
    [No Abstract]   [Full Text] [Related]  

  • 26. Ryanodine receptor type 1 (RyR1) possessing malignant hyperthermia mutation R615C exhibits heightened sensitivity to dysregulation by non-coplanar 2,2',3,5',6-pentachlorobiphenyl (PCB 95).
    Ta TA; Pessah IN
    Neurotoxicology; 2007 Jul; 28(4):770-9. PubMed ID: 17023049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional studies of RYR1 mutations in the skeletal muscle ryanodine receptor using human RYR1 complementary DNA.
    Sato K; Pollock N; Stowell KM
    Anesthesiology; 2010 Jun; 112(6):1350-4. PubMed ID: 20461000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Advances in research of malignant hyperthermia].
    Takagi A; Kojima S
    Nihon Rinsho; 1990 Jul; 48(7):1557-62. PubMed ID: 2169543
    [No Abstract]   [Full Text] [Related]  

  • 29. [Control mechanism of intracellular calcium in skeletal muscle].
    Kirino Y
    Nihon Rinsho; 1990 Jul; 48(7):1401-8. PubMed ID: 2169541
    [No Abstract]   [Full Text] [Related]  

  • 30. [King syndrome].
    Sano M
    Ryoikibetsu Shokogun Shirizu; 2001; (36):430-2. PubMed ID: 11596430
    [No Abstract]   [Full Text] [Related]  

  • 31. Malignant hyperthermia.
    Britt BA
    Clin Anesth; 1975; 11(1):61-74. PubMed ID: 1091373
    [No Abstract]   [Full Text] [Related]  

  • 32. Refinement of diagnostic assays for a probable causal mutation for porcine and human malignant hyperthermia.
    Otsu K; Phillips MS; Khanna VK; de Leon S; MacLennan DH
    Genomics; 1992 Jul; 13(3):835-7. PubMed ID: 1639409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recrudescence of malignant hyperthermia.
    Hopkins PM
    Anesthesiology; 2007 May; 106(5):893-4. PubMed ID: 17457116
    [No Abstract]   [Full Text] [Related]  

  • 34. Heat- and anesthesia-induced malignant hyperthermia in an RyR1 knock-in mouse.
    Chelu MG; Goonasekera SA; Durham WJ; Tang W; Lueck JD; Riehl J; Pessah IN; Zhang P; Bhattacharjee MB; Dirksen RT; Hamilton SL
    FASEB J; 2006 Feb; 20(2):329-30. PubMed ID: 16284304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel mutations at a CpG dinucleotide in the ryanodine receptor in malignant hyperthermia.
    Manning BM; Quane KA; Lynch PJ; Urwyler A; Tegazzin V; Krivosic-Horber R; Censier K; Comi G; Adnet P; Wolz W; Lunardi J; Muller CR; McCarthy TV
    Hum Mutat; 1998; 11(1):45-50. PubMed ID: 9450902
    [No Abstract]   [Full Text] [Related]  

  • 36. Divergent effects of the malignant hyperthermia-susceptible Arg(615)-->Cys mutation on the Ca(2+) and Mg(2+) dependence of the RyR1.
    Balog EM; Fruen BR; Shomer NH; Louis CF
    Biophys J; 2001 Oct; 81(4):2050-8. PubMed ID: 11566777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Duchenne muscular dystrophy and malignant hyperthermia: a genetic study of the ryanodine receptor in 47 patients.
    Rohde D; Schmitt HJ; Winterpacht A; Münster T
    Eur J Anaesthesiol; 2014 Jun; 31(6):341-2. PubMed ID: 24557023
    [No Abstract]   [Full Text] [Related]  

  • 38. Statin-induced adverse effects and malignant hyperthermia susceptibility: comment on the article by Guis et al.
    Vladutiu G
    Arthritis Rheum; 2007 Feb; 57(1):186-7; author reply 187-8. PubMed ID: 17266123
    [No Abstract]   [Full Text] [Related]  

  • 39. Identification and biochemical characterization of a novel ryanodine receptor gene mutation associated with malignant hyperthermia.
    Anderson AA; Brown RL; Polster B; Pollock N; Stowell KM
    Anesthesiology; 2008 Feb; 108(2):208-15. PubMed ID: 18212565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of the skeletal muscle ryanodine receptor (RYR1) gene in malignant hyperthermia and central core disease.
    MacLennan DH; Phillips MS
    Soc Gen Physiol Ser; 1995; 50():89-100. PubMed ID: 7676327
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.